Erratum: Lack of pro-convulsant activity of the antipsychotic alkaloid alstonine (Journal of Ethnopharmacology (2004) 93 (307-310) DOI: 10.1016/j.jep.2004.03.056);Lack of pro-convulsant activity of the antipsychotic alkaloid alstonine

Journal of Ethnopharmacology

Volumn 93, Issue 2-3, 2004, Pages 307-310

  Costa Campos, Luciane ^a   Iwu, Maurice ^a   Elisabetsky, Elaine ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Alstonine; Antipsychotic; Clozapine; Kindling; Seizures

Indexed keywords

ALKALOID; ALSTONINE; CLOZAPINE; CONVULSANT AGENT; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG EFFECT; KINDLING; MALE; MOUSE; NONHUMAN; SEIZURE;

EID: 3242665422     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2004.09.022     Document Type: Erratum

References (33)

1. Alldredge, B.K., 1999. Seizures risk associated with psychotropic rugs: clinical and pharmacokinetic consideration. Neurology 53, 68-75.
2. 2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the medial prefrontal cortical neurons in vitro. Neuropsychopharmacology. 18:1998;197-209
3. Breese G.R., Knapp D.J., Moy S.S. Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness. Neuroscience and Biobehavioral Reviews. 26:2002;441-455
4. Cain D.P. Long-term potentiation and kindling: how similar are the mechanisms. Trends in Neuroscience. 57:1989;37-43
5. Centorrino F., Price B.H., Tuttle M., Bahk W.M., Hennen J., Albert M.J., Baldessarini R.J. EEG abnormalities during treatment with typical and atypical antipsychotics. American Journal of Psychiatry. 159:2002;109-115
6. Costa-Campos L., Elisabetsky E., Lara D.R., Carlson T.J., King S.R., Ubilas R., Nunes D.S., Iwu M., Nkemjika O.C., Ozioko A., Agwu C.O.C. Antipsychotic profile of alstonine: ethnopharmacology of a traditional Nigerian botanical remedy. Anais da Academia Brasileira de Ciencias. 71:1999;189-201
7. Costa-Campos L., Lara D.R., Nunes D.S., Elisabetsky E. Antipsychotic-like profile of alstonine. Pharmacology Biochemistry and Behavior. 60:1998;133-141
8. Costa-Campos L., Dassoler S.C., Rigo A.P., Iwu M., Elisabetsky E. Anxiolytic properties of the antipsychotic alkaloid alstonine. Pharmacology Biochemistry Behavior. 77:2004;481-489
9. Coward D. General pharmacology of clozapine. British Journal of Psychiatry. 160:1992;3-11
10. 1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex. Brain Research. 989:2003;42-51
11. Goddard G.V., Mclntyre D.C., Leech C.K. A permanent change in brain funtion resulting from daily eletrical stimulation. Experimental Neurology. 95:1969;294-330
12. Graham S.R., Kokkinidis L. Clozapine inhibits limbic system kindling: implications for antipsychotic action. Brain Research Bulletin. 30:1993;597-605
13. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science. 297:2002;400-403
14. Heinrich H., Gibbons S. Ethnopharmacology in drug discovery: an analysis of its role and potential contribution. Journal of Pharmacy and Pharmacology. 53:2001;425-432
15. Iwu, M.M., 1993. Handbook of African Medicinal Plants. Boca Raton, FL, CRC Press Inc., pp. 219-220.
16. Iwu M.M., Court W.E. Root alkaloids of Rauwolfia comminsii Stapf. Planta Medica. 32:1977;158-161
17. Iwu M.M., Klayman D.L. Evaluation of the in vitro antimalarial activity of Picralima nitida extracts. Journal of Ethnopharmacology. 36:1992;133-135
18. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistan schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry. 45:1988;789-796
19. Knott V., Labelle A., Jones B., Mahoney C. Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment. Schizophrenia Research. 50:2001;41-53
20. Koch-Stoecker S. Antipsychotic drugs and epilepsy: indications and treatment guidelines. Epilepsia. 43:2002;19-24
21. Krystal J.H., D'Souza D.C., Mathalon D., Perry E., Belger A., Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology. 169:2003;215-233
22. Lindenmayer J.P. Treatment refractory schizophrenia. Psychiatry Quarterly. 71:2000;373-384
23. Liukkonen J., Koponen H.J., Nousiainen U. Clinical picture and long-term course of epileptic seizures that occur during clozapine treatment. Psychiatry Research. 44:1992;107-112
24. Malow B.A., Reese K.B., Sato S., Bogard P.J., Malhotra A.K., Su T.P., Pickar D. Spectrum of EEG abnormalities during clozapine treatment. Electroencephalography and Clinical Neurophysiology. 91:1994;205-211
25. Michel F.J., Trudeau L.-E. Clozapine inhibits synaptic transmission at GABAergic synapses established by ventral tegmental area neurons in culture. Neuropharmacology. 39:2000;1536-1543
26. Odebiyi A.I. Western trained nurses assessment of the different categories of traditional healers in southwestern Nigeria. International Journal of Nurse Studies. 25:1990;333-342
27. Ossawska K., Pietraszek M., Wardas J., Nowak G., Wolfarth S. Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 359:1999;280-287
28. Sajatovic M., Meltzer H.Y. Clozapine-induced myoclonus and generalized seizures. Biological Psychiatry. 39:1996;367-370
29. A receptors. Neurochemical Research. 22:1997;151-162
30. Stevens J.R. Clozapine: the Yin and Yang of seizures and psychosis. Biological Psychiatry. 37:1995;425-426
31. Stevens J.R., Denney D., Szot P. Kindling with clozapine: behavioral and molecular consequences. Epilepsy Research. 26:1996;295-304
32. Stevens J.R., Denney D., Szot P. Sensitization with clozapine: beyond the dopamine hypothesis. Biological Psychiatry. 42:1997;771-780
33. Torta R., Monaco F. Atypical antipsychotics and serotonergic antidepressants in patients with epilepsy: pharmacodynamic considerations. Epilepsia. 43:2002;8-13